Baby Aspirin Misses Mark for Primary Cardiovascular Prevention in CKD
(MedPage Today) -- DENVER -- Daily low-dose aspirin did not significantly reduce major vascular events in adults with chronic kidney disease (CKD), the randomized ATTACK trial showed. Over a mean follow-up of 3.1 years, 2.4% of adults with CKD...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.